Literature DB >> 11223975

Epstein-Barr virus-associated T cell lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin's disease.

Y Yufu1, M Kimura, R Kawano, Y Noguchi, H Takatsuki, N Uike, K Ohshima.   

Abstract

Post-transplant lymphoproliferative disorders (PTLD) of T cell type are a rare complication of solid organ and allogeneic hematopoietic cell transplantation (HCT), and usually are not associated with Epstein-Barr virus (EBV) infection. EBV-associated T cell PTLD has not been reported to occur after autologous HCT. We report an unusual case of T cell lymphoproliferation after autologous blood stem cell transplantation (ABSCT). A patient with relapsed Hodgkin's disease developed abdominal lymphadenopathy followed by atypical CD8+ lymphocytosis in the peripheral blood 30 months following ABSCT. DNA studies of the atypical lymphocytes demonstrated rearrangements of the T cell receptor beta gene and a clonal proliferation of EBV.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11223975     DOI: 10.1038/sj.bmt.1702721

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  6 in total

Review 1.  Anaplastic lymphoma kinase (ALK) protein expressing lymphoma after liver transplantation: case report and literature review.

Authors:  V Costes-Martineau; C Delfour; S Obled; L Lamant; G-P Pageaux; P Baldet; P Blanc; G Delsol
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

2.  Epstein-Barr virus-associated lymphoproliferative disorder developed following autologous peripheral blood stem cell transplantation for relapsing Hodgkin's lymphoma.

Authors:  Sakura Izumiya; Mitsuaki Ishida; Keiko Hodohara; Takashi Yoshida; Hidetoshi Okabe
Journal:  Oncol Lett       Date:  2012-04-03       Impact factor: 2.967

3.  Clinical characteristics and outcomes of posttransplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation in Korea.

Authors:  Sun Hee Park; Su Mi Choi; Dong Gun Lee; Jung Hyun Choi; Jin Hong Yoo; Hee Je Kim; Dong Wook Kim; Jong Wook Lee; Woo Sung Min; Wan Shik Shin; Chun Choo Kim
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

4.  Hodgkin's disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant glioma.

Authors:  Alberto Zambelli; Daniele Lilleri; Fausto Baldanti; Mario Scelsi; Laura Villani; Gian Antonio Da Prada
Journal:  BMC Cancer       Date:  2005-08-23       Impact factor: 4.430

5.  γ-Herpesvirus load as surrogate marker of early death in HIV-1 lymphoma patients submitted to high dose chemotherapy and autologous peripheral blood stem cell transplantation.

Authors:  Chiara Pratesi; Stefania Zanussi; Rosamaria Tedeschi; Maria Teresa Bortolin; Renato Talamini; Maurizio Rupolo; Chiara Scaini; Giancarlo Basaglia; Matteo Di Maso; Mario Mazzucato; Ernesto Zanet; Umberto Tirelli; Mariagrazia Michieli; Antonino Carbone; Paolo De Paoli
Journal:  PLoS One       Date:  2015-02-10       Impact factor: 3.240

6.  An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastoma.

Authors:  J L Powell; N J Bunin; C Callahan; R Aplenc; G Griffin; S A Grupp
Journal:  Bone Marrow Transplant       Date:  2004-03       Impact factor: 5.483

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.